Financial Ratios

DR. DATASONS LABS LTD.

NSE : NABSE : 533412ISIN CODE : INE928K01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE6.290 (0 %)
PREV CLOSE ( ) 6.29
OPEN PRICE ( ) 6.29
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 6.29 (1397430)
VOLUME 802500
TODAY'S LOW / HIGH ( )6.29 6.29
52 WK LOW / HIGH ( ) 6.296.29
NSE
This Company is not listed in NSE
Select year
ParticularsMar2014Mar2013Mar2012Mar2011Mar2010
Operational & Financial Ratios
   Earnings Per Share (Rs)0.210.4029.5447.5326.10
   CEPS(Rs)6.6714.9640.8350.9427.62
   DPS(Rs)0.000.100.000.000.00
   Book NAV/Share(Rs)128.85222.84251.89177.3786.16
   Tax Rate(%)47.7480.1734.9234.0334.03
Margin Ratios
   Core EBITDA Margin(%)13.5120.3221.9722.0518.11
   EBIT Margin(%)10.528.7319.2021.3117.89
   Pre Tax Margin(%)0.310.5313.1417.0414.14
   PAT Margin (%)0.160.118.5511.249.33
   Cash Profit Margin (%)5.013.9911.8112.059.87
Performance Ratios
   ROA(%)0.060.068.1016.7615.43
   ROE(%)0.190.1716.9539.1148.57
   ROCE(%)5.036.0319.9935.6636.29
   Asset Turnover(x)0.360.590.951.491.65
   Sales/Fixed Asset(x)1.692.163.115.205.17
   Working Capital/Sales(x)35.671.684.494.032.67
Efficiency Ratios
   Fixed Capital/Sales(x)0.590.460.320.190.19
   Receivable days276.65165.74110.6676.2283.78
   Inventory Days152.58106.5483.6167.4858.00
   Payable days245.8393.8417.597.5123.15
Valuation Parameters
   PER(x)198.11333.9118.480.000.00
   PCE(x)6.328.8413.370.000.00
   Price/Book(x)0.330.592.170.000.00
   Yield(%)0.000.080.00
   EV/Net Sales(x)1.491.002.190.460.40
   EV/Core EBITDA(x)9.684.729.762.062.17
   EV/EBIT(x)14.1411.4711.422.142.24
   EV/CE(x)0.500.491.470.490.48
   M Cap / Sales0.320.351.580.000.00
Growth Ratio
   Net Sales Growth(%)-19.158.5049.8798.0979.37
   Core EBITDA Growth(%)-41.422.5452.21137.66173.17
   EBIT Growth(%)-2.50-50.6735.01135.95178.30
   PAT Growth(%)22.54-98.6613.93138.85195.21
   EPS Growth(%)-46.24-98.66-37.8482.10152.96
Financial Stability Ratios
   Total Debt/Equity(x)1.211.780.851.031.20
   Current Ratio(x)1.021.831.421.813.64
   Quick Ratio(x)0.741.390.880.972.07
   Interest Cover(x)1.031.063.175.004.77
   Total Debt/Mcap(x)3.713.000.39

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.